Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 92786

5 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 02, 2023
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Parker Laboratories, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

5 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 5

Protex Foaming Hand Sanitizer (Benzalkonium Chloride 0.13%), packaged in a) 2 fl oz/60 mL Pump bottles (NDC 30775-040-02) and b)18 fl. oz./550 ml Pump Bottles (NDC 30775-040-18), Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004

D-1089-2023
Recall number
D-1089-2023
Initiated
August 02, 2023
Classification
Class II
Status
Terminated
Recalling firm
Parker Laboratories, Inc.
Quantity
9

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

Lot #: a) G0323002, Exp. Date 3/1/2025 Lot #: b) G1122001, Exp. Date 11/15/2024

Distribution pattern

Nationwide within the United States, Singapore, Korea and Hong Kong

drug · product 2 of 5

Helix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-on (NDC 30775-051-03), c) 4 fl. oz. tubes (NDC 30775-051-04), d) 12 fl oz pump bottles (NDC 30775-051-12), e) 32 fl. oz. pump bottles (NDC 30775-051-32), f) 1 U.S. gallon with pump (NDC 30775-051-50), g) Starter Kit (NDC 30775-051-95), Parker Laboratories, Inc. 286 Eldridge Road Fairfield, NJ 07004

D-1090-2023
Recall number
D-1090-2023
Initiated
August 02, 2023
Classification
Class II
Status
Terminated
Recalling firm
Parker Laboratories, Inc.
Quantity
250

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

a) J0721010, Exp. Date 6/30/2024; J1022017, Exp. Date 10/27/2025; b) A0521002, Exp. Date 4/29/2024; c) A0322006, Exp. Date 3/2/2025, A0323004, Exp. Date 2/24/2026, A0422005, Exp. Date 3/14/2025, A0521001, Exp. Date 4/29/2024, A0822004, Exp. Date 7/27/2025, d) C0222001, Exp. Date 6/30/2023, C0521003, Exp. Date 4/29/2023, C0822005, Exp. Date 7/27/2024, e)C0721019, Exp. Date 6/30/2024, f) C0521001, Exp. Date 4/29/2024, C0721022, Exp. Date 6/30/2024, C0822006, Exp. Date 7/27/2025, g) C0323006, C0821022, C0922006, Exp. Date 4/29/2024, C1221003, Exp. Date 4/09/2024

Distribution pattern

Nationwide within the United States, Singapore, Korea and Hong Kong

drug · product 3 of 5

Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz. roll-on (NDC 30775-052-03) and b) 4 fl. oz. tube (NDC 30775-052-04) Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004

D-1091-2023
Recall number
D-1091-2023
Initiated
August 02, 2023
Classification
Class II
Status
Terminated
Recalling firm
Parker Laboratories, Inc.
Quantity
8

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

Lot #: a) A1221010, Exp. Date 12/9/2023, b) A1221011, Exp date 12/9/2023

Distribution pattern

Nationwide within the United States, Singapore, Korea and Hong Kong

drug · product 4 of 5

Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004

D-1092-2023
Recall number
D-1092-2023
Initiated
August 02, 2023
Classification
Class II
Status
Terminated
Recalling firm
Parker Laboratories, Inc.
Quantity
40

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

Lot #: a) J1121010, Exp. Date 12/16/2023, b) A0921006, Exp. Date 8/16/2023, c) A0921007, Exp. Date 8/16/2023

Distribution pattern

Nationwide within the United States, Singapore, Korea and Hong Kong

drug · product 5 of 5

Helix CBD Clinical Cream (Menthol 7.4%), packaged in a)3 gm pouches (NDC30775-054-01), b)2 fl. oz. tubes (NDC 30775-054-02), and c) 4 fl. oz. tubes (NDC 30775-054-04), Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004

D-1093-2023
Recall number
D-1093-2023
Initiated
August 02, 2023
Classification
Class II
Status
Terminated
Recalling firm
Parker Laboratories, Inc.
Quantity
50

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

Lot #: a) J1121011, Exp. Date 12/21/2023, b) A0921009, Exp. Date 8/18/2023, c) A0921008, Exp. Date 8/18/2023

Distribution pattern

Nationwide within the United States, Singapore, Korea and Hong Kong